We compared different clinicopathological features of HCC patients and found that ARHGAP24 downregulation was significantly correlated with satellite lesions (P = 0.031), CNLC stage (P = 0.020), microvascular invasion (P = 0.001) and tumor recurrence (P = 0.002) (Figure 1I, Table S2). The gene discussed is ARHGAP24; the disease is neoplasm.